Beta-carotene Supplementation Reduces Micronuclei in Smokers' Sputum
Author Information
Author(s): G. van Poppel, F.J. Kok, R.J.J. Hermus
Primary Institution: TNO Toxicology and Nutrition Institute
Hypothesis
Does beta-carotene supplementation reduce the frequency of micronuclei in sputum among heavy smokers?
Conclusion
Beta-carotene supplementation may reduce lung cancer risk by preventing DNA damage in early-stage carcinogenesis.
Supporting Evidence
- Micronuclei counts were significantly higher in the beta-carotene group at baseline.
- The treatment group showed a 47% decrease in micronuclei counts.
- After adjustment, the treatment group had 27% lower micronuclei counts than the placebo group.
Takeaway
Taking beta-carotene can help smokers have fewer signs of DNA damage in their spit, which might mean a lower chance of getting lung cancer.
Methodology
A double-blind, randomized, placebo-controlled trial over 14 weeks with blood and sputum samples collected before and after treatment.
Potential Biases
The study may have biases due to the initial unequal distribution of micronuclei counts between groups.
Limitations
Initial higher micronuclei counts in the treatment group indicate potential issues with randomization.
Participant Demographics
Healthy male smokers, aged approximately 40 years, smoking at least 15 cigarettes per day for over 2 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 9-41%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website